Utilize a smartphone or computer to connect with professionals committed to personalized care, and allow us to handle complex insurance interactions, prior authorizations, and ongoing care, enabling you to dedicate your energy to achieving healthier outcomes
Despite production costs being estimated at under $5 per month, the branded pricing creates a substantial financial barrier, especially for patients requiring chronic therapy
Regulatory authorities require comprehensive impurity characterization, and peptide mapping via LC-MS/MS has become the gold standard for this purpose, as outlined in regulatory requirements for GLP-1 peptide characterization
December 2022
The Sentosa SQ HCV Genotyping Assay (VELA Diagnostics GmbH, Hamburg, Germany) is a novel deep sequencing-based in vitro diagnostic test comprising a customized version of the epMotion 5075 robotic liquid handling system for RNA extraction and sequence library preparation (Sentosa SX101), a customized version of an Ion One Touch device for template preparation including emulsion PCR (Sentosa ST401), the Ion Torrent technology for deep sequencing (Sentosa SQ301), and software for data analysis and reporting (Sentosa Link and Sentosa Reporter, respectively)